Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 6.3.2023Instituto Grifols, S.A. (GFO)9185DAlbutein 200 g/l infúzny roztok (sol inf 1x100 ml (fľ.skl.))6.3.2023R
 6.3.2023Vertex Pharmaceuticals (Ireland) Limited (VET-IE-1)6412DKalydeco 75 mg filmom obalené tablety (tbl flm 28x75 mg (blis.aclar/Al))10.3.2023U
 6.3.2023Vertex Pharmaceuticals (Ireland) Limited (VET-IE-1)9628DKaftrio 37,5 mg/25 mg/50 mg filmom obalené tablety (tbl flm 56x37,5 mg/25 mg/50 mg)10.3.2023U
 3.3.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)0218AAMIRAP 5 mg/5 mg tvrdé kapsuly (cps dur 30x5 mg/5 mg (blis.Al/OPA/Al/PVC))1.3.2023R
 3.3.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)18614Amoksiklav 625 mg (tbl flm 21x625 mg (blis.Al/Al))1.3.2023O
 3.3.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)5431ATelmisartan/Hydrochlorotiazid Sandoz 80 mg/12,5 mg (tbl obd 28x80 mg/12,5 mg (blis.Al/Al))1.3.2023R
 3.3.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)5782AVorikonazol Sandoz 200 mg filmom obalené tablety (tbl flm 14x200 mg (blis.PVC/PVDC/Al))1.3.2023R
 3.3.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)58702TAMOXIFEN Sandoz 20 mg (tbl 100x20 mg (liek.PP))1.3.2023R
 3.3.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)7569BEplerenon Sandoz 25 mg filmom obalené tablety (tbl flm 90x25 mg (blis.PVC/Al))1.3.2023R
 3.3.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)7726BDuloxetin Sandoz 60 mg (cps end 30x60 mg (blis.PVC/PE/PCTFE/Al))1.3.2023R
 3.3.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)7726BDuloxetin Sandoz 60 mg (cps end 30x60 mg (blis.PVC/PE/PCTFE/Al))4.5.2022O
 3.3.2023Teva Czech Industries s.r.o. (TEV-CZ-2)5569BStoptussin sirup (sir 1x180 ml (fľ.skl.hnedá + dávkov.pipeta))10.3.2023O
 3.3.2023Teva Czech Industries s.r.o. (TEV-CZ-2)88900STOPTUSSIN (gto por 1x25 ml (fľ.skl. s kvapk.))3.3.2023O
 3.3.2023CSL Behring GmbH (CSL)50936Privigen 100 mg/ml infúzny intravenózny roztok (sol inf 1x200 ml (liek.inj.skl.))3.3.2023R
 3.3.2023Berlin-Chemie AG (BCE)9771CProstamol uno (cps mol 90x320 mg (blis.PVC/PVDC/Al))6.3.2023R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)